CHF33.58
3.51% yesterday
SIX Swiss Exchange, Nov 15, 05:31 pm CET
ISIN
CH0042615283
Symbol
DOCM

DocMorris Target price 2024 - Analyst rating & recommendation

DocMorris Classifications & Recommendation:

Buy
46%
Hold
46%
Sell
8%

DocMorris Price Target

Target Price CHF52.31
Price CHF33.58
Potential
Number of Estimates 13
13 Analysts have issued a price target DocMorris 2025 . The average DocMorris target price is CHF52.31. This is higher than the current stock price. The highest price target is
CHF90.00 168.02%
register free of charge
, the lowest is .
A rating was issued by 13 analysts: 6 Analysts recommend DocMorris to buy, 6 to hold and 1 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the DocMorris stock has an average upside potential 2025 of . Most analysts recommend the DocMorris stock at Buy or hold.

Sales and Margin forecast 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Dec '23 2024
Estimates
Revenue Billion CHF 0.97 1.04
39.72% 7.79%
EBITDA Margin -3.34% -4.58%
46.23% 37.04%
Net Margin -12.94% -9.61%
1.75% 25.74%

13 Analysts have issued a sales forecast DocMorris 2024 . The average DocMorris sales estimate is

CHF1.0b
Unlock
. This is
4.20% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
CHF1.1b 11.69%
Unlock
, the lowest is
CHF1.0b 0.18%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2023 CHF969m 39.72%
2024
CHF1.0b 7.79%
Unlock
2025
CHF1.3b 23.20%
Unlock
2026
CHF1.6b 23.62%
Unlock
2027
CHF1.6b 3.60%
Unlock
2028
CHF1.9b 13.52%
Unlock

13 Analysts have issued an DocMorris EBITDA forecast 2024. The average DocMorris EBITDA estimate is

CHF-47.9m
Unlock
. This is
50.08% lower
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
CHF-35.5m 11.40%
Unlock
, the lowest is
CHF-57.0m 78.74%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2023 CHF-32.4m 67.59%
2024
CHF-47.9m 47.72%
Unlock
2025
CHF-10.2m 78.76%
Unlock
2026
CHF35.6m 450.18%
Unlock
2027
CHF37.7m 6.00%
Unlock
2028
CHF91.3m 141.87%
Unlock

EBITDA Margin

2023 -3.34% 46.23%
2024
-4.58% 37.04%
Unlock
2025
-0.79% 82.75%
Unlock
2026
2.24% 383.54%
Unlock
2027
2.29% 2.23%
Unlock
2028
4.88% 113.10%
Unlock

11 DocMorris Analysts have issued a net profit forecast 2024. The average DocMorris net profit estimate is

CHF-100m
Unlock
. This is
5.60% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
CHF-90.0m 15.38%
Unlock
, the lowest is
CHF-113m 6.05%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2023 CHF-125m 38.66%
2024
CHF-100m 19.94%
Unlock
2025
CHF-70.9m 29.44%
Unlock
2026
CHF-28.8m 59.37%
Unlock
2027
CHF-10.8m 62.66%
Unlock
2028
CHF35.8m 433.12%
Unlock

Net Margin

2023 -12.94% 1.75%
2024
-9.61% 25.74%
Unlock
2025
-5.50% 42.77%
Unlock
2026
-1.81% 67.09%
Unlock
2027
-0.65% 64.09%
Unlock
2028
1.91% 393.85%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Dec '23 2024
Estimates
Earnings Per Share CHF -9.74 -7.80
38.66% 19.92%
P/E negative
EV/Sales 0.61

11 Analysts have issued a DocMorris forecast for earnings per share. The average DocMorris <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

CHF-7.80
Unlock
. This is
5.57% higher
Unlock
than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
CHF-6.99 15.38%
Unlock
, the lowest is
CHF-8.76 6.05%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2023 CHF-9.74 38.66%
2024
CHF-7.80 19.92%
Unlock
2025
CHF-5.50 29.49%
Unlock
2026
CHF-2.24 59.27%
Unlock
2027
CHF-0.83 62.95%
Unlock
2028
CHF2.78 434.94%
Unlock

P/E ratio

Current -4.06 15.34%
2024
-4.31 6.16%
Unlock
2025
-6.10 41.53%
Unlock
2026
-15.02 146.23%
Unlock
2027
-40.24 167.91%
Unlock
2028
12.08 130.02%
Unlock

Based on analysts' sales estimates for 2024, the DocMorris stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 0.64 20.75%
2024
0.61 4.20%
Unlock
2025
0.50 18.84%
Unlock
2026
0.40 19.11%
Unlock
2027
0.39 3.48%
Unlock
2028
0.34 11.89%
Unlock

P/S ratio

Current 0.43 6.33%
2024
0.41 4.03%
Unlock
2025
0.34 18.84%
Unlock
2026
0.27 19.11%
Unlock
2027
0.26 3.45%
Unlock
2028
0.23 11.91%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today